GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (WBO:DXCM) » Definitions » NonCurrent Deferred Liabilities

DexCom (WBO:DXCM) NonCurrent Deferred Liabilities : €7 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DexCom NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

DexCom's non-current deferred liabilities for the quarter that ended in Mar. 2024 was €7 Mil.

DexCom NonCurrent Deferred Liabilities Historical Data

The historical data trend for DexCom's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom NonCurrent Deferred Liabilities Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 19.47 17.94 6.79

DexCom Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.82 24.18 24.27 6.79 6.81

DexCom NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of DexCom's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom (WBO:DXCM) Business Description

Traded in Other Exchanges
Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom (WBO:DXCM) Headlines